13F-HR filed by Sio Capital Management, LLC
Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 66 holding rows worth $302,285,000.
- Accession
- 0001214659-22-006910
- Filer
- CIK 1482416
- Filed
- 2022-05-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A holdings report, 66 entries on the cover page, a total value of $302,285,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $302,285,000 with VALUE read as thousands by filing date, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 133,000 | $34,709,000 | thousands by filing date | put |
| MEDICUS SCIENCES ACQUISITION | G5960S108 | CL A SHS | 2,323,000 | $22,719,000 | thousands by filing date | |
| Cigna Corporation | 125523100 | COM | 67,830 | $16,253,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 195,160 | $16,013,000 | thousands by filing date | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 300,000 | $15,402,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 58,500 | $15,267,000 | thousands by filing date | call |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 49,328 | $13,006,000 | thousands by filing date | |
| INOGEN INC | 45780L104 | COM | 400,086 | $12,971,000 | thousands by filing date | |
| CENCORA INC COM | 03073E105 | Stock | 83,271 | $12,883,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 34,501 | $10,562,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 55,262 | $9,915,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 146,696 | $9,098,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 96,762 | $8,146,000 | thousands by filing date | |
| VAREX IMAGING CORP | 92214X106 | COMMON STOCK | 315,486 | $6,717,000 | thousands by filing date | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 175,568 | $6,503,000 | thousands by filing date | |
| NATUS MEDICAL INC | 639050103 | COM | 191,564 | $5,034,000 | thousands by filing date | |
| VAPOTHERM INC | 922107107 | COM | 353,006 | $4,907,000 | thousands by filing date | |
| MEDPACE HLDGS INC COM | 58506Q109 | Stock | 28,400 | $4,646,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 1,915,460 | $4,559,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 144,546 | $4,312,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 693,700 | $3,739,000 | thousands by filing date | put |
| INARI MED INC | 45332Y109 | COM | 40,210 | $3,645,000 | thousands by filing date | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 161,285 | $3,551,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 105,756 | $3,233,000 | thousands by filing date | |
| RENOVACOR INC | 75989E106 | COM | 735,908 | $3,120,000 | thousands by filing date | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 377,684 | $3,010,000 | thousands by filing date | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 999,829 | $2,999,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 643,664 | $2,813,000 | thousands by filing date | |
| INHIBRX INC | 45720L107 | COM | 124,250 | $2,768,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 250,000 | $2,478,000 | thousands by filing date | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W114 | UNIT 10/23/2027 | 248,674 | $2,452,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 90,000 | $2,380,000 | thousands by filing date | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 52,788 | $2,316,000 | thousands by filing date | |
| PARDES BIOSCIENCES INC | 69945Q105 | COM | 315,564 | $2,278,000 | thousands by filing date | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 259,763 | $2,018,000 | thousands by filing date | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 871,101 | $2,004,000 | thousands by filing date | |
| MOLECULIN BIOTECH INC | 60855D200 | COMMON | 1,040,529 | $1,852,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 162,478 | $1,838,000 | thousands by filing date | |
| CONNECT BIOPHARMA HLDGS LTD | 207523101 | SHS | 597,678 | $1,805,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 562,339 | $1,749,000 | thousands by filing date | |
| Ohr Pharmaceutical Inc | 64132K102 | COM | 906,445 | $1,704,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U404 | CMN | 48,768 | $1,563,000 | thousands by filing date | |
| ISOPLEXIS CORP | 465005106 | COM | 407,102 | $1,396,000 | thousands by filing date | |
| CYCLACEL PHARMACE 6percent PFDCONV | 23254L603 | Stock | 422,598 | $1,289,000 | thousands by filing date | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 111,033 | $1,188,000 | thousands by filing date | |
| ASLAN PHARMACEUTICALS LTD | 04522R101 | ADR | 1,270,758 | $1,143,000 | thousands by filing date | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 40,000 | $1,124,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 902,907 | $1,074,000 | thousands by filing date | |
| SAVARA INC | 805111101 | COM | 716,262 | $938,000 | thousands by filing date | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 359,731 | $907,000 | thousands by filing date | |
| NEXTCURE INC | 65343E108 | COM | 130,000 | $632,000 | thousands by filing date | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 276,909 | $485,000 | thousands by filing date | |
| AVEANNA HEALTHCARE HLDGS INC | 05356F105 | COM | 131,812 | $449,000 | thousands by filing date | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 102,049 | $408,000 | thousands by filing date | |
| RADIUS HEALTH INC | 750469207 | COM NEW | 44,400 | $392,000 | thousands by filing date | |
| NYXOAH S A | B6S7WD106 | SHS | 16,110 | $308,000 | thousands by filing date | |
| BAUSCH HEALTH COS INC COM | 071734107 | Stock | 12,100 | $276,000 | thousands by filing date | put |
| AYALA PHARMACEUTICALS INC | 05465V108 | COM | 60,220 | $240,000 | thousands by filing date | |
| KODIAK SCIENCES INC | 50015M109 | COM | 30,600 | $236,000 | thousands by filing date | call |
| CAREMAX INC | 14171W103 | COM | 30,741 | $230,000 | thousands by filing date | |
| Renovacor Inc | 75989E114 | Warrant | 400,000 | $168,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 9,168 | $152,000 | thousands by filing date | |
| LOGICBIO THERAPEUTICS INC | 54142F102 | COM | 182,630 | $124,000 | thousands by filing date | |
| Humacyte Inc W Exp 08/27/202 | 44486Q111 | SPAC Combination | 49,998 | $97,000 | thousands by filing date | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 38,312 | $72,000 | thousands by filing date | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 12,808 | $20,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-22-006910 | this filing | 2022-05-16 | acceptance time not in the bulk data set |